|Invuity Inc -- USA Stock|| |
USD 9.25 0.1 1.07%
Senior Vice President of Global Sales
Mr. Andrew Sale is Senior Vice President of Global Sales of the Company, since January of 2017. Prior to joining us, Mr. Sale served as Vice President at Alpha Genomix Laboratories from August 2015 to June 2016. From April 2004 to December 2014, Mr. Sale served in a variety of roles at Intuitive Surgical, a publicly traded manufacturer of robotic surgical systems, including Sales Manager, Sales Director, Area Vice President, Regional Vice President and in his last role was responsible for all the U.S. capital business. Prior to Intuitive Surgical, Mr. Sale spent six years at Johnson Johnson, where he provided sales and sales leadership in key specialty companies inside of Ethicon to drive the growth of emerging products
Age: 44 President Since 2017
Sale received a B.A. in General Studies from Louisiana State University.
The company has return on total asset (ROA)
of (50.37) %
which means that it has lost $50.37 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (244.8) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 22.88 M in liabilities with Debt to Equity (D/E) ratio of 178.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Invuity Inc has Current Ratio of 3.01 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Invuity, Inc., a medical technology company, develops various surgical devices to address various surgical procedures in the United States. Invuity Inc (IVTY) is traded on NASDAQ General Markets in USA. It is located in CALIFORNIA, U.S.A and employs 163 people. Invuity is listed under Medical Equipment category by Fama And French industry classification.